Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Castellani, Rudy J.a; b; * | Smith, Margaretb | Bailey, Kristib | Perry, Georgec | deJong, Joyce L.b
Affiliations: [a] Department of Pathology, Anatomy, and Laboratory Medicine, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, USA | [b] Department of Pathology, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, USA | [c] College of Sciences, University of Texas, San Antonio, San Antonio, TX, USA
Correspondence: [*] Correspondence to: Rudy J. Castellani, MD, 64 Medical Center Drive, 2289 HSC-S, MS 9203, Morgantown, WV 26506-9203, USA. Tel.: +1 304 293 1625; Fax: +1 304 293 1627; E-mail: [email protected].
Abstract: Traumatic brain injury (TBI) is widely assumed to be causal in neurodegenerative disease, based on epidemiological surveys demonstrating an increased risk of Alzheimer disease (AD) following TBI, and on recent theories surrounding repetitive head movement. We tested this assumption by evaluating 30 consecutive forensic examinations in which neuropathology consultation was sought, and in which a history of remote TBI was uncovered during the course of the investigation. In this series, there was a high frequency of psychiatric co-morbidities (100%), remote contusion (90%), and seizures (63%). Extent of proteinopathy showed no differences with age-matched controls. A subset of the cases showed focal geographic tauopathy that correlated with older age at autopsy, but had no correlation with clinical signs, and was minimal in comparison with the encephalomalacia secondary to trauma. The results suggest that cerebral contusion and post-traumatic epilepsy may be over-represented in civilian TBI, while structural brain damage from trauma is the predominant cause of morbidity following TBI. We found no evidence that TBI initiates a progressive proteinopathy.
Keywords: Alzheimer’s disease, Amyloid-β, contusion, epilepsy, neurodegenerative disease, phosphorylated tau, traumatic brain injury
DOI: 10.3233/JAD-190782
Journal: Journal of Alzheimer's Disease, vol. 72, no. 3, pp. 683-691, 2019
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]